- Home
- NMRA vs HBCP Comparison
NMRA vs HBCP Comparison
Compare NMRA & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NMRA | HBCP |
|---|---|---|
| Founded | 2019 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.0M | 453.4M |
| IPO Year | 2023 | 2008 |
Fundamental Metrics
Financial Performance| Metric | NMRA | HBCP |
|---|---|---|
| Price | $2.00 | $61.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $6.57 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 1.0M | 102.9K |
| Earning Date | 05-11-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.01% |
| EPS Growth | 5.23 | ★ 29.01 |
| EPS | N/A | ★ 5.87 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.74 |
| P/E Ratio | ★ N/A | $10.52 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $40.10 |
| 52 Week High | $3.65 | $64.17 |
Technical Indicators
Market Signals| Indicator | NMRA | HBCP |
|---|---|---|
| Relative Strength Index (RSI) | 30.05 | 57.10 |
| Support Level | $1.78 | $56.27 |
| Resistance Level | $2.20 | $63.46 |
| Average True Range (ATR) | 0.17 | 1.83 |
| MACD | -0.09 | 0.25 |
| Stochastic Oscillator | 13.41 | 73.34 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.